Most relevant to NM-induced skin injury, we recently reported the identification of a novel MARCO+ fibrosis-driving macrophages and inflammatory monocytes in skin lesions of a mouse model scleroderma induced by the chemotherapeutic drug, bleomycin (BLM)16. Here, MARCO is linked to scleroderma.